Financing channel feed – Endpoints News

Financing channel feed

Bicara, Zenas outline plans for $180M IPOs amid restored optimism for biotech debuts

8 months ago

Exclusive: Lilly-backed OrsoBio raises $67M for slate of obesity drugs as combinations take root

8 months ago

MDLive veterans nab $7.5M Series A for virtual specialty care startup

8 months ago

Exclusive: ZipBio launches using generative AI to make compact proteins

8 months ago

Transplant biotech eGenesis snags $191M after first use of gene-edited pig kidney

8 months ago

Cell therapy startup ArsenalBio raises $325M as it runs early solid tumor trials

8 months ago

BioAge files for IPO, riding momentum for weight loss drugs

8 months ago

Exclusive: Noetik raises $40M Series A to advance AI ambitions in cancer — with an unlikely lead investor

8 months ago

Duality Biologics, an ADC partner of BeiGene and BioNTech, files for Hong Kong IPO

8 months ago

Former Regenxbio leaders take rare disease gene therapies to startup with $15M

8 months ago

Elektrofi, a startup that helps drugmakers formulate biologics for easier delivery, is raising a $112M Series C

8 months ago

RA Capital and Forbion set up new autoimmune biotech with bispecific from Korean startup

8 months ago

Major Galapagos investor says it will push board on company's 'performance' and 'strategic opportunities'

8 months ago

Peptide biotech MBX submits IPO plans, making a trio of post-Labor Day Nasdaq hopefuls

8 months ago

Oncology biotech Bicara unveils IPO pitch same day as Zenas

8 months ago

Autoimmune biotech Zenas files for IPO amid summer lull for public debuts

8 months ago

Illumina Ventures sets out for $300M third fund

8 months ago

Versant and Novartis build 'Chinook 2.0' for RNA therapies in kidney diseases

8 months ago

BridgeBio forms another offshoot with $300M in commitments

8 months ago

After Pfizer layoffs, Array chemists regather at next-gen obesity biotech Ambrosia Biosciences

8 months ago

TCGX and JPM help Pathalys raise $105M to go up against Amgen in subset of kidney disease

8 months ago

TYK Medicines seeks to launch new EGFR drug in China with $74M Hong Kong IPO

8 months ago

Investment in early-stage health tech startups climbed in the first half of 2024, report shows

9 months ago

Sanofi backs AnaptysBio’s $100M offering, helping catapult the biotech’s stock

9 months ago

First page Previous page 8 9 101112 13 14 Next page Last page